SCHEDULE 13D/AAccepted May 14, 4:36 PM ET
Apellis Pharmaceuticals, Inc. SCHEDULE 13D/A
Accepted (ET)
4:36 PM
May 14, 2026
Filed
May 14, 2026
Documents
1
Size
9.1 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.